rs7334118

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The ENST00000242839.10(ATP7B):ā€‹c.3620A>Gā€‹(p.His1207Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0154 in 1,614,212 control chromosomes in the GnomAD database, including 768 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H1207Y) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.027 ( 122 hom., cov: 33)
Exomes š‘“: 0.014 ( 646 hom. )

Consequence

ATP7B
ENST00000242839.10 missense

Scores

1
6
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:19

Conservation

PhyloP100: 3.46
Variant links:
Genes affected
ATP7B (HGNC:870): (ATPase copper transporting beta) This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in ENST00000242839.10
BP4
Computational evidence support a benign effect (MetaRNN=0.0022899806).
BP6
Variant 13-51939130-T-C is Benign according to our data. Variant chr13-51939130-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 35724.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-51939130-T-C is described in Lovd as [Benign]. Variant chr13-51939130-T-C is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0889 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATP7BNM_000053.4 linkuse as main transcriptc.3620A>G p.His1207Arg missense_variant 17/21 ENST00000242839.10 NP_000044.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATP7BENST00000242839.10 linkuse as main transcriptc.3620A>G p.His1207Arg missense_variant 17/211 NM_000053.4 ENSP00000242839 P1P35670-1

Frequencies

GnomAD3 genomes
AF:
0.0273
AC:
4153
AN:
152214
Hom.:
122
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0472
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.0931
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.00910
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00910
Gnomad OTH
AF:
0.0220
GnomAD3 exomes
AF:
0.0296
AC:
7396
AN:
249590
Hom.:
461
AF XY:
0.0244
AC XY:
3302
AN XY:
135400
show subpopulations
Gnomad AFR exome
AF:
0.0488
Gnomad AMR exome
AF:
0.148
Gnomad ASJ exome
AF:
0.00496
Gnomad EAS exome
AF:
0.000389
Gnomad SAS exome
AF:
0.0109
Gnomad FIN exome
AF:
0.00213
Gnomad NFE exome
AF:
0.00844
Gnomad OTH exome
AF:
0.0208
GnomAD4 exome
AF:
0.0141
AC:
20647
AN:
1461880
Hom.:
646
Cov.:
32
AF XY:
0.0135
AC XY:
9805
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.0483
Gnomad4 AMR exome
AF:
0.141
Gnomad4 ASJ exome
AF:
0.00505
Gnomad4 EAS exome
AF:
0.000504
Gnomad4 SAS exome
AF:
0.0121
Gnomad4 FIN exome
AF:
0.00266
Gnomad4 NFE exome
AF:
0.00939
Gnomad4 OTH exome
AF:
0.0148
GnomAD4 genome
AF:
0.0273
AC:
4162
AN:
152332
Hom.:
122
Cov.:
33
AF XY:
0.0277
AC XY:
2066
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.0473
Gnomad4 AMR
AF:
0.0930
Gnomad4 ASJ
AF:
0.00375
Gnomad4 EAS
AF:
0.00154
Gnomad4 SAS
AF:
0.00870
Gnomad4 FIN
AF:
0.00160
Gnomad4 NFE
AF:
0.00910
Gnomad4 OTH
AF:
0.0223
Alfa
AF:
0.0135
Hom.:
77
Bravo
AF:
0.0360
TwinsUK
AF:
0.0113
AC:
42
ALSPAC
AF:
0.00830
AC:
32
ESP6500AA
AF:
0.0532
AC:
232
ESP6500EA
AF:
0.00866
AC:
74
ExAC
AF:
0.0257
AC:
3112
Asia WGS
AF:
0.0240
AC:
83
AN:
3478
EpiCase
AF:
0.00785
EpiControl
AF:
0.00830

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:19
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Wilson disease Benign:11
Benign, no assertion criteria providedclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 17, 2012- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 05, 2018- -
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthSep 27, 2024- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 28, 2023- -
Benign, criteria provided, single submitterclinical testingCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterSep 22, 2024- -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not specified Benign:6
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 26, 2013- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoNov 23, 2016- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 08, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 06, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Pathogenic
0.89
D;D;.;.;.;.;.
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.12
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.81
T;T;T;T;T;T;T
MetaRNN
Benign
0.0023
T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.10
T
MutationAssessor
Benign
-1.2
N;.;.;.;.;.;.
MutationTaster
Benign
1.0
D;D;D;D;D;D;D
PrimateAI
Uncertain
0.62
T
PROVEAN
Uncertain
-4.3
D;D;D;D;D;.;D
REVEL
Uncertain
0.46
Sift
Benign
0.089
T;D;T;T;T;.;T
Sift4G
Benign
0.32
T;T;T;T;T;T;T
Polyphen
0.044
B;D;B;B;B;B;B
Vest4
0.14
MPC
0.094
ClinPred
0.061
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.30
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7334118; hg19: chr13-52513266; API